Steven Jandrich

Steven Jandrich, listed as senior executive, appears in our data through filings on Inspire Medical Systems, Inc. shares, published by SEC (Form 4). Between 7 May 2018 and 30 January 2024, the trades on record add up to 38 filings.

Both buying and selling appear: 3 purchases worth €27k, against 13 sales worth €6.2M. The net balance comes to €6.2M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 16 option exercises.

The median purchase comes to €4,693.

The latest filing, published on 31 January 2024, reports an option exercise of €14k in Inspire Medical Systems, Inc. The latest purchase dates back some time: it was published 3,106 days ago, on 9 May 2018. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.